Erdal Cavusoglu1, Jonathan D Marmur2, Sandeep Chhabra2, Mohammad R Hojjati2, Sunitha Yanamadala2, Vineet Chopra3, Calvin Eng3, Xian-Cheng Jiang4. 1. Division of Cardiology, Department of Medicine, Bronx Veterans Affairs Medical Center, Bronx, NY, USA; Division of Cardiology, Department of Medicine, SUNY Downstate Medical Center, Brooklyn, NY, USA. Electronic address: ECavusoglu@aol.com. 2. Division of Cardiology, Department of Medicine, SUNY Downstate Medical Center, Brooklyn, NY, USA. 3. Division of Cardiology, Department of Medicine, Bronx Veterans Affairs Medical Center, Bronx, NY, USA. 4. Department of Anatomy and Cell Biology, SUNY Downstate Medical Center, Brooklyn, NY, USA.
Abstract
OBJECTIVES: To investigate the long-term prognostic significance of baseline plasma PLTP levels in a group of well-characterized male patients with diabetes mellitus and known or suspected coronary artery disease referred for coronary angiography. BACKGROUND: PLTP is a plasma protein that mediates the net transfer and exchange of phospholipids between lipoproteins. It has been implicated in the pathogenesis of atherosclerosis and elevated plasma levels have been reported in patients with diabetes mellitus. METHODS: Baseline plasma PLTP levels were measured in 154 male patients with diabetes mellitus who were referred for coronary angiography and followed prospectively for 5 years for the development of all-cause mortality. RESULTS: After adjustment for a variety of baseline clinical, angiographic and laboratory parameters, plasma PLTP levels (analyzed as a continuous variable) were an independent predictor of all-cause mortality at 5 years (HR, 1.55; 95% CI, 1.22-2.00; P = 0.0009). Furthermore, in 3 additional multivariate models that also included a wide variety of contemporary biomarkers with established prognostic efficacy (i.e., ST2, GDF-15, Cystatin C, Fibrinogen, and NT-proBNP), PLTP remained an independent predictor of all-cause mortality at 5 years. CONCLUSIONS: Elevated baseline plasma levels of PLTP are associated with an increased risk of long-term all-cause mortality in patients with diabetes and known or suspected coronary disease. Furthermore, this association is independent of a variety of clinical, angiographic, and laboratory variables, including a whole host of contemporary biomarkers with established prognostic efficacy.
OBJECTIVES: To investigate the long-term prognostic significance of baseline plasma PLTP levels in a group of well-characterized male patients with diabetes mellitus and known or suspected coronary artery disease referred for coronary angiography. BACKGROUND:PLTP is a plasma protein that mediates the net transfer and exchange of phospholipids between lipoproteins. It has been implicated in the pathogenesis of atherosclerosis and elevated plasma levels have been reported in patients with diabetes mellitus. METHODS: Baseline plasma PLTP levels were measured in 154 male patients with diabetes mellitus who were referred for coronary angiography and followed prospectively for 5 years for the development of all-cause mortality. RESULTS: After adjustment for a variety of baseline clinical, angiographic and laboratory parameters, plasma PLTP levels (analyzed as a continuous variable) were an independent predictor of all-cause mortality at 5 years (HR, 1.55; 95% CI, 1.22-2.00; P = 0.0009). Furthermore, in 3 additional multivariate models that also included a wide variety of contemporary biomarkers with established prognostic efficacy (i.e., ST2, GDF-15, Cystatin C, Fibrinogen, and NT-proBNP), PLTP remained an independent predictor of all-cause mortality at 5 years. CONCLUSIONS: Elevated baseline plasma levels of PLTP are associated with an increased risk of long-term all-cause mortality in patients with diabetes and known or suspected coronary disease. Furthermore, this association is independent of a variety of clinical, angiographic, and laboratory variables, including a whole host of contemporary biomarkers with established prognostic efficacy.
Authors: R de Vries; A K Groen; F G Perton; G M Dallinga-Thie; M J A van Wijland; L D Dikkeschei; B H R Wolffenbuttel; A van Tol; R P F Dullaart Journal: Atherosclerosis Date: 2007-02-01 Impact factor: 5.162
Authors: Martina Schneider; Bruno Vergès; Alexis Klein; Elizabeth R Miller; Valérie Deckert; Catherine Desrumaux; David Masson; Philippe Gambert; Jean-Marcel Brun; Jamila Fruchart-Najib; Denis Blache; Joseph L Witztum; Laurent Lagrost Journal: Diabetes Date: 2004-10 Impact factor: 9.461
Authors: N Sarwar; P Gao; S R Kondapally Seshasai; R Gobin; S Kaptoge; E Di Angelantonio; E Ingelsson; D A Lawlor; E Selvin; M Stampfer; C D A Stehouwer; S Lewington; L Pennells; A Thompson; N Sattar; I R White; K K Ray; J Danesh Journal: Lancet Date: 2010-06-26 Impact factor: 202.731
Authors: Suyi Xie; Qi Li; Andrea O Y Luk; Hui-Yao Lan; Paul K S Chan; Antoni Bayés-Genís; Francis K L Chan; Erik Fung Journal: Biomolecules Date: 2022-07-04
Authors: Graziella E Ronsein; Tomas Vaisar; W Sean Davidson; Karin E Bornfeldt; Jeffrey L Probstfield; Kevin D O'Brien; Xue-Qiao Zhao; Jay W Heinecke Journal: Arterioscler Thromb Vasc Biol Date: 2021-06-17 Impact factor: 10.514